HighGravityDataHumana — Feb 11, 2025 release
Fiscal 2024 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-25-000004
Showing in the filing
Individual Medicare Advantage annual membership decline
“approximately 550,000, or approximately 10 percent”
Period
FY2025
Measure
Company-defined measure
Source
Prose
All guidance in this release · 24
Adjusted FY 2025 EPS for FY2025
“at least in line with 2024 results”
GAAP EPS for FY2025
“approximately $15.88”
GAAP EPS for FY2025
“approximately $15.88”
Adjusted (non-GAAP) EPS for FY2025
“approximately $16.25”
Adjusted EPS for FY2025
“approximately $16.25”
Diluted earnings per share (Adjusted non-GAAP) for FY2025
“approximately $16.25”
Individual Medicare Advantage annual members… for FY2025
“approximately 550,000, or approximately 10 percent”
Diluted earnings per common share - GAAP for FY2025
“approximately $15.88”
Total Revenues Consolidated - GAAP for FY2025
“$126 billion to $128 billion”
Total Revenues Insurance segment - GAAP for FY2025
“$121 billion to $123 billion”
Total Revenues CenterWell segment - GAAP for FY2025
“$20.5 billion to $21.5 billion”
Change in year-end medical membership from p… for FY2025
“Decline of approximately 550,000”
Change in year-end medical membership from p… for FY2025
“Relatively flat”
Change in year-end medical membership from p… for FY2025
“Growth of approximately 200,000”
Change in year-end medical membership from p… for FY2025
“Growth within 175,000 to 250,000 range”
Benefit Ratio Insurance segment - GAAP for FY2025
“90.1% to 90.5%”
Operating Cost Ratio - Consolidated GAAP for FY2025
“11.3% to 11.7%”
Segment Results: Insurance segment income fr… for FY2025
“GAAP: $1.5 billion to $2.0 billion”
CenterWell segment income from operations - … for FY2025
“$1.0 billion to $1.5 billion”
CenterWell segment income from operations - … for FY2025
“$1.2 billion to $1.7 billion”
Effective Tax Rate - GAAP for FY2025
“approximately 25.0%”
Weighted Avg. Share Count for Diluted EPS for FY2025
“approximately 121.5 million”
Cash flows from operations - GAAP for FY2025
“$2.4 billion to $2.9 billion”
Capital expenditures for FY2025
“approximately $650 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Box 1438 Louisville, KY 40202 http://www.humana.com FOR MORE INFORMATION CONTACT: Lisa Stoner Humana Investor Relations (502) 580-2652 e-mail: LStamper@humana.com Mark Taylor Humana Corporate Communications (317) 753-0345 e-mail: MTaylor108@humana.com Humana Reports Fourth Quarter 2024 Financial Results; Provides Full Year 2025 Financial Guidance • Reports 4Q24 net loss per share of $5.76 on a GAAP basis, Adjusted net loss per share of $2.16; reports FY 2024 earnings per share (EPS) of $9.98 on a GAAP basis, $16.21 on an Adjusted basis • 4Q24 Insurance segment Adjusted benefit ratio of 91.9 percent, which includes a 20-basis point increase related to incremental Star Ratings investments, was consistent with expectations • Affirms previous commentary of Adjusted FY 2025 EPS guidance to be 'at least in line with 2024 results'; anticipating GAAP EPS of approximately $15.88, or approximately $16.25 on an Adjusted basis, inclusive of incremental investments to support operational excellence • Expects individual Medicare Advantage annual membership decline of approximately 550,000, or approximately 10 percent, from 2024, inclusive of the company's decision to exit certain unprofitable plans and counties • Continuing to advance Medicaid and CenterWell strategies; expected to drive increased earnings contribution over the mid and longer term • Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9:00 a.m. ET question and answer session to discuss its financial results for the quarter and expectations for future earnings LOUISVILLE, KY (February 11, 2025) – Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net (loss) earnings per share for the quarter ended December 31, 2024 (4Q24) versus the quarter ended December 31, 2023 (4Q23) and for the year ended December 31, 2024 (FY 2024) versus the year ended December 31, 2023 (FY 2023) as noted in the tables below. 1 Consolidated (loss) income before income taxes and equity in net losses (pretax results) In millions 4Q24 (a) 4Q23 (a) FY 2024 (a) FY 2023 (a) Generally Accepted Accounting Principles (GAAP) ($862) ($591) $1,721 $3,383 Amortization associated with identifiable intangibles 14 15 60 67 Put/call valuation adjustments associated with the company's non-consolidatin
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.